T&L Co Ltd
KOSDAQ:340570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
T&L Co Ltd
Other Current Assets
T&L Co Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Other Current Assets
₩909.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Other Current Assets
₩7.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
SD Biosensor Inc
KRX:137310
|
Other Current Assets
₩150.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
124%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Other Current Assets
₩4B
|
CAGR 3-Years
123%
|
CAGR 5-Years
97%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Other Current Assets
₩12B
|
CAGR 3-Years
39%
|
CAGR 5-Years
9%
|
CAGR 10-Years
39%
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Other Current Assets
₩10.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
51%
|
|
T&L Co Ltd
Glance View
T&L Co., Ltd. develops medical polymer material products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2020-11-20. The firm's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The firm sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
See Also
What is T&L Co Ltd's Other Current Assets?
Other Current Assets
909.1m
KRW
Based on the financial report for Dec 31, 2024, T&L Co Ltd's Other Current Assets amounts to 909.1m KRW.
What is T&L Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
25%
Over the last year, the Other Current Assets growth was 7%. The average annual Other Current Assets growth rates for T&L Co Ltd have been 20% over the past three years , 25% over the past five years .
